Advances in molecular diagnosis

Current Opinion in Obstetrics and Gynecology

Volumn 8, Issue 2, 1996, Pages 130-134

  Korf, Bruce R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME LOSS; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGEORGE SYNDROME; DNA DETERMINATION; GENE DELETION; GENETIC LINKAGE; GENETIC SCREENING; HEREDITARY SPINAL MUSCULAR ATROPHY; HUMAN; METABOLIC DISORDER; PATHOGENESIS; PRADER WILLI SYNDROME; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; WILLIAMS BEUREN SYNDROME;

EID: 0029917726     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199604000-00010     Document Type: Review

References (24)

1. Lowery MC, Morris CA, Ewart A, Brothman LJ, Zhu XL, Leonard CO, Carey JC, Keating M, Brothman AR: Strong correlation of elastin deletions, detected by FISH, with Williams syndrome: evaluation of 235 patients. Am J Hum Genet 1995, 57:49-53.
2. Borg I, Delhanty JDA, Baraitser M: Detection of hemizygosity at the elastin locus by FISH analysis as a diagnostic test in both classical and atypical cases of Williams syndrome. J Med Genet 1995, 32:692-696.
3. Morrow B, Goldberg R, Carlson C, Das Gupta R, Sirotkin H, Collins J, Dunham I, O'Donnell H, Scambler P, Shprintzen R, Kucherlapati R: Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. Am J Hum Genet 1995, 56:1391-1403.
4. White L, Knoll JHM: Angelman syndrome: validation of molecular cytogenetic analysis of chromosome 15q11-q13 for deletion detection. Am J Med Genet 1995, 56:101-105.
5. Saitoh S, Harada N, Jinno Y, Hashimoto K, Imaizumi K, Kuroki Y, Fukushima Y, Sugimoto T, Renedo M, Wagstaff J et al.: Molecular and clinical study of 61 Angelman syndrome patients. Am J Med Genet 1994, 52:158-163.
6. van den Ouweland AMW, van der Est MN, Wesby-van Swaay E, Tijmensen TSLN, Los FJ, van Hemel JO, Hennekam RCM, Meijers-Heijboer HJ, Niermeijer MF, Halley DJJ: DNA diagnosis of Prader-Willi and Angelman syndromes with the probe PW71 (D15S63). Hum Genet 1995, 95:562-567.
7. n dinucleotide repeat polymorphisms. Am J Med Genet 1994, 52:79-84.
8. Buiting K, Dittrich B, Robinson WP, Guitart M, Abeliovich D, Lerer I, Horsthemke B: Detection of aberrant DNA methylation in unique Prader-Willi syndrome patients and its diagnostic implications. Hum Mol Genet 1994, 3:893-895.
9. Lindor NM, Karnes PS, Michels W, Dewald GW, Goerss J, Jalal S, Jenkins RB, Vockley G, Thibodeau SN: Uniparental disomy in congenital disorders: a prospective study. Am J Med Genet 1995, 58:143-146.
10. Ledbetter DH, Engel E: Uniparental disomy in humans: development of an imprinting map and its implications for prenatal diagnosis. Hum Mol Genet 1995, 4:1757-1764.
11. Richards S, Iannaccone ST: Dystrophin and DNA diagnosis in a large pediatric muscle clinic. J Child Neural 1994, 9:162-166.
12. Katayama S, Takeshita N, Yano T, Katagiri Y, Shirosita Y, Kubo H, Hirakawa S, Ubagai T: Prenatal diagnosis of Duchenne muscular dystrophy by polymerase chain reaction analysis. Fetal Diagn Ther 1994, 9:379-384.
13. Fassati A, Tedeschi S, Bordono A, Amboni P, Curcio C, Bresolin N, Scarlato G: Rapid direct diagnosis of deletions carriers of Duchenne and Becker muscular dystrophies. Lancet 1994, 344:302-303.
14. Wang X, Seaman C, Paik M, Chen T, Bank A, Piomelli S: Experience with 500 prenatal diagnoses of sickle cell disease: the effect of gestational age on affected pregnancy outcome. Prenat Diagn 1994, 14:851-857.
15. Heim RA, Kam-Morgan LNW, Binnie CG, Corns DD, Cayouette MC, Farber RA, Aylsworth AS, Silverman LM, Luce MC: Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 1995, 4:975-981.
16. Gardner RJ, Bobrow M, Roberts RG: The identification of point mutations in Duchenne muscular dystrophy patients by using reverse-transcription PCR and the protein truncation test. Am J Hum Genet 1995, 57:311-320.
17. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 1995, 11:198-200.
18. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malmgren H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I et al.: A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StBI2.3: the first 2,253 cases. Am J Hum Genet 1994, 55:225-237.
19. Rousseau O, Boulot P, Lefort G, Nagy P, Bachelard B, Bonifacj C, Hedon B, Laffargue F, Viala JL: Amniocentesis before 15 weeks' gestation: technical aspects and obstetric risks. Eur J Obstet Gynecol Reprod Biol 1995, 58:127-130.
20. Rossiter JP, Blakemore KJ, Kickler TS, Kasch LM, Khouzami N, Pressman EK, Sciscione AC, Kazazian HH Jr: The use of polymerase chain reaction to determine fetal RhD status. Am J Obstet Gynecol 1994, 171:1047-1051.
21. Livingstone J, Axton RA, Gilfillan A, Mennie M, Compton M, Liston WA, Calder AA, Gordon AJ, Brock DJH: Antenatal screening for cystic fibrosis: a trial of the couple model. BMJ 1994, 308:1459-1462.
22. Miedzybrodzka ZH, Hall MH, Mollison J, Templeton A, Russell IT, Dean JCS, Kelly KF, Marteau TM, Haites NE: Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening. BMJ 1995, 310:353-357.
23. Super M, Schwarz MJ, Malone G, Roberts T, Haworth A, Dermody G: Active cascade testing for carriers of cystic fibrosis gene. BMJ 1994, 308:1462-1467.
24. Benjamin CM, Adam S, Wiggins S, Theilmann JL, Copley TT, Bloch M, Squitieri F, McKellin W, Cox S, Brown SA, et al.: Proceed with care: direct predictive testing for Huntington disease. Am J Hum Genet 1994, 55:606-617.